BioNTech SE (BNTX) Financials

BNTX Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 24.2 billion 2.7 billion
Dec. 31, 2025 25.8 billion 3.2 billion
Sept. 30, 2025 25.0 billion 3.4 billion
June 30, 2025 25.5 billion 3.7 billion

BNTX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -556.5 million 26.1 million
Dec. 31, 2025 279.0 million 28.3 million
Sept. 30, 2025 951.9 million 32.7 million
June 30, 2025 825.1 million 37.8 million

BNTX Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 -619.6 million
Dec. 31, 2025 -354.7 million
Sept. 30, 2025 -39.4 million
June 30, 2025 -516.9 million

BNTX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 16.8 billion - 282.3 million
Dec. 31, 2025 17.4 billion 35.1 million 217.4 million
Sept. 30, 2025 17.0 billion 29.6 million 242.9 million
June 30, 2025 16.5 billion 256.0 million -

BNTX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 289.8 million
Dec. 31, 2025 287.8 million
Sept. 30, 2025 280.7 million
June 30, 2025 284.8 million

BNTX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 66.2 million 648.8 million 34.4 million -
Dec. 31, 2025 72.2 million 587.8 million 342.4 million 57.9 million
Sept. 30, 2025 51.0 million 662.8 million 174.3 million 32.0 million
June 30, 2025 669.4 million 600.1 million 161.9 million 23.2 million

BNTX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 137.6 million 224.5 million
Dec. 31, 2025 1.1 billion 387.6 million
Sept. 30, 2025 1.8 billion 174.0 million
June 30, 2025 307.4 million 90.0 million

BNTX

Price: $88.08

52 week price:
79.52
124.00

Payout Ratio Range:
0.43%
28.97%

Earnings Per Share: -5.97 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: Germany

Volume: 379200

Market Capitalization: 23.6 billion

Links: